These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Review: Combination umeclidinium/vilanterol improved health status more than umeclidinium in COPD. Stanbrook MB Ann Intern Med; 2015 Dec; 163(12):JC10. PubMed ID: 26666800 [No Abstract] [Full Text] [Related]
10. Fluticasone-vilanterol combination approved for COPD. Traynor K Am J Health Syst Pharm; 2013 Jun; 70(12):1008. PubMed ID: 23719869 [No Abstract] [Full Text] [Related]
12. New drugs 2015, part 2. Hussar DA Nursing; 2015 Jul; 45(7):34-41; quiz 41-2. PubMed ID: 26083291 [No Abstract] [Full Text] [Related]
13. Apremilast, albiglutide, and empagliflozin. Hussar DA; Yenner S J Am Pharm Assoc (2003); 2014; 54(5):562-6. PubMed ID: 25216888 [No Abstract] [Full Text] [Related]
14. Drug updates and approvals: 2017 in review. Mospan G; Mospan C; Vance S; Bradshaw A; Meosky K; Bowles K Nurse Pract; 2017 Dec; 42(12):8-16. PubMed ID: 29176433 [TBL] [Abstract][Full Text] [Related]
15. Umeclidinium bromide and vilanterol in combination for the treatment of chronic obstructive pulmonary disease. Kelly E Expert Rev Clin Pharmacol; 2014 Jul; 7(4):403-13. PubMed ID: 24909949 [TBL] [Abstract][Full Text] [Related]
17. New drugs 2014, part 3. Hussar DA Nursing; 2014 Oct; 44(10):28-34. PubMed ID: 25153167 [No Abstract] [Full Text] [Related]
18. A new conjugated estrogen. Med Lett Drugs Ther; 1999 Jul; 41(1058):67-8. PubMed ID: 10445019 [No Abstract] [Full Text] [Related]
19. Dapagliflozin approved for type 2 diabetes. Traynor K Am J Health Syst Pharm; 2014 Feb; 71(4):263. PubMed ID: 24481146 [No Abstract] [Full Text] [Related]
20. The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects. Feldman GJ; Edin A Ther Adv Respir Dis; 2013 Dec; 7(6):311-9. PubMed ID: 24004659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]